{"ticker": {"uuid": "199912d2-a2c3-4d30-9045-a6651baeedb8", "symbol": "207940", "name": "Samsung Biologics Co.,Ltd.", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Samsung Biologics stock trades near record levels as contract manufacturing demand supports revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPWkxGRElEaVlzc2gxazFjd2JBNS1QbTBpaWNZS1Nvb1V1UlJ6OEFGdzNETElBWms0RHhGYzJ2aFhydTRtVW1BSlhfR3hhWThVWFl4TTY4TnN4M1VqaVJOcVhyS2JuMkZ0TWluMGpYaHZ5SldnZmlISmdnd0c3VXJUNjc1dmhaUUhUSUxOV0dUa1c0Q21Bc1ZKc2tZRTVBQndpYTVZV1gzMWhYcHZVaXpvQm5MMkhJTHdGbFdBMg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-16T20:35:24+00:00", "published_display": "16 Jul 2026 20:35", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics expands global biotech reach as contract pipeline grows", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNUFRVa3poNTRPLXRjQlIxZ3pUM0xfOXRiaHJsVktDQUU1Z21GYjBoWUlvdkVrdUNSTlc1N3p4Uk9HaU5YSnh4TjRKVy10U19HcTJQZGs2RFlYQ1h2U2V1eTBQZTA2TTktYXgzMzZCVGkyeGtIdnZfVjQ0TnBmZ1UwWXJ5RmdJWTltM1VhSElXMk9fNVNxMThLd3VnSFE5NWpGRnlOeWlmaWVRU2JscUo0RV9JZFJvT3EtZlc2YllmNTRkMnFvYlpMb21kVlY?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-08T17:46:40+00:00", "published_display": "08 Jul 2026 17:46", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of SAMSUNG BIOLOGICS Co., Ltd. \u2013 KRX:207940", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOZDY3c3JsSFp6dkNLOWJwNjBKUHpxM1N6MWJuaGdIT2dmRHpKMzBiZzBWS0pGYU4tTzdtQmRJUmxFeHBBekxhZVlQRVFGbXhaMmVsMU1oZTRMNGFWQklwUmc1WkdZc3Z2NG5nVkxILUFYZzB6eElFS243cF9YX0lNNXZSdEtWS2Q4MDI0Q3EyUTdYOGdZM0JMLURMbXFVOGhYTldsNXJzSC1WVVU?oc=5", "source_name": "TradingView", "published_at": "2026-06-30T05:46:16+00:00", "published_display": "30 Jun 2026 05:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics Stock - Sunday background on capacity and pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOU1ZlVTZibGhxc1FYZjJSRGpjdHdDcmFfYlRzSzc0ZVB3NmVheDM3a090VDNfeENvTDlodS1VeEpwZmNuejNzTUVlM1BTcjkxTjZCWFQ3ZmlvV1VnQXNBNlFldExUeGZmcU9kNDZLbnVQOVVtODctU2Z4bE0wdTJVN04wUmxhMElwYU5adDJPT25JWHVkeEdhZFIxbFhLOWotaUJQcUptRk9PSUQwbGlSc1ZjRm5TdFdrTkJWQzBHY1ROLWM?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Electro-Mechanics Tops 1 Million Won, Joining \"Emperor Stock\" Club", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQWEs5bHZoanBKUkduSU5lcDYzNVE3UDZzRUQ4QVZocjAyVmtrUTk4XzlyR0M2a1BuX2RUeVdDdjBIeWp1YzRWc3FxOG01UV9kcWczeXNKWDJ5azhpanlFVFljbFNEZERxc0N5TUVzbjVLeUpFWXB5NTVvaXZYWWFpRGN1SzNCWVZ0OWxIVEhLZEVqd1dPc2hTTl9n?oc=5", "source_name": "Seoul Economic Daily", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics stock (KR7207940008): CDMO leader navigates South Korea biotech landscape", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPZGNtcHBydUdNakdtekpvTjVPR3RTTnlNd1F2VTV5NE0zcjEyeXVmaHBydFc1WWF4U0lNRDZ3d2hTekt2UWFNZ0pXVldBdEFBVXpucDA5UW44eEgwN3owYTRTb1JsS0lQZlBvYmZPNVRwbG5wRHk2OWlsaHhoT21uRWtRVmlncWdZd05UMmZleE1SUUJNT2ppYzZoTmpmR2l5cllxakpPTWlUQ0pMVUZ3eWtPZk0teWtoN05WekdRcUdjaFltSDJ5UQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung is adding trials and EHR access to Galaxy devices", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPNVJPVHVKSmJEN0Etd2ZqeUxEcng2R250Q2tYU3JVUTgyR0Q4NW9kSTdiVHU0eFBjMS1xNktiYUdYR3hnM2M0U2lHb04zQjBEMzFnMGYxTlRaVHRGUEJuSTNDMVpBLUtnRVRqZzY0OUJqLTNFbGFrMUhiRHFQdGxDa2syQ09fclBPcng0eExjUzh5amY3X29iU19Kb09XYlU?oc=5", "source_name": "BioWorld News", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics to buy US drug production facility from GSK for $280 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQVm5mdUY1c09oZDRveTJMcmdXS1JyakM1dWYzMjFZLThZbVlFS3Z5NkxXTjFCRGdhdWJIR1Z5OWNmaXV1V1Nhck1EcE9fZ193RUhKTzg5VlM1WjdXRDVfNS1OUTlhUldXVDJ6dVBINHV2SHRLZkIwWVBOSVVNRDdEUGtJY0x6R2gtRFdfSmhHbjFDeHhteXdYSDk0dzE3RW1tRDc0UkxJcU5MOG5CNGlPLXpjX2ZkelV4YWt0bjNPbHV6TXNJcFZjWlFBOWdxZw?oc=5", "source_name": "Reuters", "published_at": "2025-12-21T08:00:00+00:00", "published_display": "21 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Samyang Holdings, Samsung Biologics spin-offs debut on Kospi", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQYUtLXzNUV09ZbkxncEp4NVFLT050QVQ0Y3BLWU9BSm1JTGs2aGN6MkxTTnlqYTI2c2t0cUM3dF9Kd1B4S21OczE0WEV3N2dNNVpiNFJ4X1V5d21TLTJ1RnBXRmFtTjBWblpBeHhScmJxeWlWa3dLRnlDYThETi1tdVRuN25mTXZ4bmhzekhCM09PN09vX1ctSHJHcGctNGdOQmFHZzE5VQ?oc=5", "source_name": "BioWorld News", "published_at": "2025-11-25T08:00:00+00:00", "published_display": "25 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQTDNVaHJBUmJIYnJWSG9HNGVZZ2ZDLW52RVg1akRkYkMtTk1iNWd3MTJCU01aQl9CMEpLOFBHYWdwLWNMYzZuWkYwbGc3QW9kNkFudGlCc1RLNVhldGdubmV6bnZ4cjhEc3BxM0NjMGxoel9oTGtXd2w4NmpBbTlxRTBNTGhBaVBXWkN5cW05Q1NsOXNaSmM3d2lUcFd3SFUtanpZT3RQRWZuc2N5QjhDU082RU01bS10emVTMXlCV1FpcDNnUVZnWjItMGFpUWZ2dHc?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics to spin off biosimilar subsidiary Samsung Bioepis", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNSk1lMFhhWC1sd1lSUVdBYzR2b0cwb3ZrcU96TkQzWldMSVVYYzl4bnk2RGNzZ1drZGZtVW1wTHViSkRlNWZwVzhSdzlDRkhIZGQydmprTEZEZEFHX09rc1BTaHQxaDR0aE1oSkU4VXBkNTY0V1FRUVhieXNPWVZSUTZZUFhFa0FIMWRPbU1XWGFDT0REcXYzVmJPRTZUR3NUWTlsZFRsX3J6ZTlO?oc=5", "source_name": "BioWorld News", "published_at": "2025-05-22T07:00:00+00:00", "published_display": "22 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Bioepis, Celltrion make biosimilar inroads in Europe, US", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNdGJqaXpITVZ5QVpRaVdTSmwxby1ZcHJiamdwczQ3R3Q4RHFNU3ZENVJDUUNNcGlDR2JjNjI0N0gtTVpPZVFFVmdLQjdJSVBNZ3ZNZFNJcmRBbWlJd2haMVpxaHdfODMyaGFNLUtrQW05U2Jxcmt3TUpUQjVqYTB6UW83UWFDTWVhM25hR3pQSG5nRkxIZ0dIMUNYMlVvWFJmS2hfQ2l3?oc=5", "source_name": "BioWorld News", "published_at": "2024-04-23T07:00:00+00:00", "published_display": "23 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung BioLogics says decision pending on making Moderna vaccine as report ignites share", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOQmxFRkgteFZxYWVfNVRLc2tJUUhtaWFJQTh5d0RYa3p3MjNFZ1p1RlB2ZzRfeE9TcVhFY2lYcEdMN21UWEhRdlhoTVVJY0xaYkdsSHNLeG5aR3Z2R0tzNS1JMm50TW1QRk5GNjJ1Z0dmM093Q3lHNFJCN1VfdFhzQksteWEwX1ZVUTNHb0hvWHFrR0FHN1VMVXpJbGZicFlYUzczTUFLU2tTZHFXWXVnbUFaYjM5WGJfOWtVb1NuMl9YbFNkNXA5RzMySHlOSWtxcVFpSnZzVWhPUVk?oc=5", "source_name": "Reuters", "published_at": "2021-05-13T07:00:00+00:00", "published_display": "13 May 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung BioLogics, Pfizer deny report on COVID-19 vaccine production in S.Korea", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPRHRxcVFQN2JDWWl5NHhPaHAtOXdUN3c3c0hFa1Fza01ZWkVLV1VOcWxBM1BLRHF2ZkJ0NWZmaXlJRlkxTVRlMjFEOXNXTUxwMjdsbVEtcUhwVExhcVhNNDhzT3BxRUpxak9KUEwwM0hiNkRwLUFXQ3JqTXZCT0JUdnVNRXA5S3pNTk5pbEFIcThMY3hJbFJYdVM1NFBOYUJqQUJLYTVVZFk2b2hBQkhzWkh4cnVUYk1fb3ZZenBGNkFGSVBMVW9Vbw?oc=5", "source_name": "Reuters", "published_at": "2021-05-12T07:00:00+00:00", "published_display": "12 May 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Samsung Biologics stock trades near record levels as contract manufacturing demand supports revenue", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPWkxGRElEaVlzc2gxazFjd2JBNS1QbTBpaWNZS1Nvb1V1UlJ6OEFGdzNETElBWms0RHhGYzJ2aFhydTRtVW1BSlhfR3hhWThVWFl4TTY4TnN4M1VqaVJOcVhyS2JuMkZ0TWluMGpYaHZ5SldnZmlISmdnd0c3VXJUNjc1dmhaUUhUSUxOV0dUa1c0Q21Bc1ZKc2tZRTVBQndpYTVZV1gzMWhYcHZVaXpvQm5MMkhJTHdGbFdBMg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-16T20:35:24+00:00", "published_display": "16 Jul 2026 20:35", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics expands global biotech reach as contract pipeline grows", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNUFRVa3poNTRPLXRjQlIxZ3pUM0xfOXRiaHJsVktDQUU1Z21GYjBoWUlvdkVrdUNSTlc1N3p4Uk9HaU5YSnh4TjRKVy10U19HcTJQZGs2RFlYQ1h2U2V1eTBQZTA2TTktYXgzMzZCVGkyeGtIdnZfVjQ0TnBmZ1UwWXJ5RmdJWTltM1VhSElXMk9fNVNxMThLd3VnSFE5NWpGRnlOeWlmaWVRU2JscUo0RV9JZFJvT3EtZlc2YllmNTRkMnFvYlpMb21kVlY?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-08T17:46:40+00:00", "published_display": "08 Jul 2026 17:46", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of SAMSUNG BIOLOGICS Co., Ltd. \u2013 KRX:207940", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOZDY3c3JsSFp6dkNLOWJwNjBKUHpxM1N6MWJuaGdIT2dmRHpKMzBiZzBWS0pGYU4tTzdtQmRJUmxFeHBBekxhZVlQRVFGbXhaMmVsMU1oZTRMNGFWQklwUmc1WkdZc3Z2NG5nVkxILUFYZzB6eElFS243cF9YX0lNNXZSdEtWS2Q4MDI0Q3EyUTdYOGdZM0JMLURMbXFVOGhYTldsNXJzSC1WVVU?oc=5", "source_name": "TradingView", "published_at": "2026-06-30T05:46:16+00:00", "published_display": "30 Jun 2026 05:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics Stock - Sunday background on capacity and pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOU1ZlVTZibGhxc1FYZjJSRGpjdHdDcmFfYlRzSzc0ZVB3NmVheDM3a090VDNfeENvTDlodS1VeEpwZmNuejNzTUVlM1BTcjkxTjZCWFQ3ZmlvV1VnQXNBNlFldExUeGZmcU9kNDZLbnVQOVVtODctU2Z4bE0wdTJVN04wUmxhMElwYU5adDJPT25JWHVkeEdhZFIxbFhLOWotaUJQcUptRk9PSUQwbGlSc1ZjRm5TdFdrTkJWQzBHY1ROLWM?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Electro-Mechanics Tops 1 Million Won, Joining \"Emperor Stock\" Club", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQWEs5bHZoanBKUkduSU5lcDYzNVE3UDZzRUQ4QVZocjAyVmtrUTk4XzlyR0M2a1BuX2RUeVdDdjBIeWp1YzRWc3FxOG01UV9kcWczeXNKWDJ5azhpanlFVFljbFNEZERxc0N5TUVzbjVLeUpFWXB5NTVvaXZYWWFpRGN1SzNCWVZ0OWxIVEhLZEVqd1dPc2hTTl9n?oc=5", "source_name": "Seoul Economic Daily", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics stock (KR7207940008): CDMO leader navigates South Korea biotech landscape", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPZGNtcHBydUdNakdtekpvTjVPR3RTTnlNd1F2VTV5NE0zcjEyeXVmaHBydFc1WWF4U0lNRDZ3d2hTekt2UWFNZ0pXVldBdEFBVXpucDA5UW44eEgwN3owYTRTb1JsS0lQZlBvYmZPNVRwbG5wRHk2OWlsaHhoT21uRWtRVmlncWdZd05UMmZleE1SUUJNT2ppYzZoTmpmR2l5cllxakpPTWlUQ0pMVUZ3eWtPZk0teWtoN05WekdRcUdjaFltSDJ5UQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung is adding trials and EHR access to Galaxy devices", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPNVJPVHVKSmJEN0Etd2ZqeUxEcng2R250Q2tYU3JVUTgyR0Q4NW9kSTdiVHU0eFBjMS1xNktiYUdYR3hnM2M0U2lHb04zQjBEMzFnMGYxTlRaVHRGUEJuSTNDMVpBLUtnRVRqZzY0OUJqLTNFbGFrMUhiRHFQdGxDa2syQ09fclBPcng0eExjUzh5amY3X29iU19Kb09XYlU?oc=5", "source_name": "BioWorld News", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics to buy US drug production facility from GSK for $280 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQVm5mdUY1c09oZDRveTJMcmdXS1JyakM1dWYzMjFZLThZbVlFS3Z5NkxXTjFCRGdhdWJIR1Z5OWNmaXV1V1Nhck1EcE9fZ193RUhKTzg5VlM1WjdXRDVfNS1OUTlhUldXVDJ6dVBINHV2SHRLZkIwWVBOSVVNRDdEUGtJY0x6R2gtRFdfSmhHbjFDeHhteXdYSDk0dzE3RW1tRDc0UkxJcU5MOG5CNGlPLXpjX2ZkelV4YWt0bjNPbHV6TXNJcFZjWlFBOWdxZw?oc=5", "source_name": "Reuters", "published_at": "2025-12-21T08:00:00+00:00", "published_display": "21 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Samyang Holdings, Samsung Biologics spin-offs debut on Kospi", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQYUtLXzNUV09ZbkxncEp4NVFLT050QVQ0Y3BLWU9BSm1JTGs2aGN6MkxTTnlqYTI2c2t0cUM3dF9Kd1B4S21OczE0WEV3N2dNNVpiNFJ4X1V5d21TLTJ1RnBXRmFtTjBWblpBeHhScmJxeWlWa3dLRnlDYThETi1tdVRuN25mTXZ4bmhzekhCM09PN09vX1ctSHJHcGctNGdOQmFHZzE5VQ?oc=5", "source_name": "BioWorld News", "published_at": "2025-11-25T08:00:00+00:00", "published_display": "25 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQTDNVaHJBUmJIYnJWSG9HNGVZZ2ZDLW52RVg1akRkYkMtTk1iNWd3MTJCU01aQl9CMEpLOFBHYWdwLWNMYzZuWkYwbGc3QW9kNkFudGlCc1RLNVhldGdubmV6bnZ4cjhEc3BxM0NjMGxoel9oTGtXd2w4NmpBbTlxRTBNTGhBaVBXWkN5cW05Q1NsOXNaSmM3d2lUcFd3SFUtanpZT3RQRWZuc2N5QjhDU082RU01bS10emVTMXlCV1FpcDNnUVZnWjItMGFpUWZ2dHc?oc=5", "source_name": "PR Newswire", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Biologics to spin off biosimilar subsidiary Samsung Bioepis", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNSk1lMFhhWC1sd1lSUVdBYzR2b0cwb3ZrcU96TkQzWldMSVVYYzl4bnk2RGNzZ1drZGZtVW1wTHViSkRlNWZwVzhSdzlDRkhIZGQydmprTEZEZEFHX09rc1BTaHQxaDR0aE1oSkU4VXBkNTY0V1FRUVhieXNPWVZSUTZZUFhFa0FIMWRPbU1XWGFDT0REcXYzVmJPRTZUR3NUWTlsZFRsX3J6ZTlO?oc=5", "source_name": "BioWorld News", "published_at": "2025-05-22T07:00:00+00:00", "published_display": "22 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung Bioepis, Celltrion make biosimilar inroads in Europe, US", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNdGJqaXpITVZ5QVpRaVdTSmwxby1ZcHJiamdwczQ3R3Q4RHFNU3ZENVJDUUNNcGlDR2JjNjI0N0gtTVpPZVFFVmdLQjdJSVBNZ3ZNZFNJcmRBbWlJd2haMVpxaHdfODMyaGFNLUtrQW05U2Jxcmt3TUpUQjVqYTB6UW83UWFDTWVhM25hR3pQSG5nRkxIZ0dIMUNYMlVvWFJmS2hfQ2l3?oc=5", "source_name": "BioWorld News", "published_at": "2024-04-23T07:00:00+00:00", "published_display": "23 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung BioLogics says decision pending on making Moderna vaccine as report ignites share", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOQmxFRkgteFZxYWVfNVRLc2tJUUhtaWFJQTh5d0RYa3p3MjNFZ1p1RlB2ZzRfeE9TcVhFY2lYcEdMN21UWEhRdlhoTVVJY0xaYkdsSHNLeG5aR3Z2R0tzNS1JMm50TW1QRk5GNjJ1Z0dmM093Q3lHNFJCN1VfdFhzQksteWEwX1ZVUTNHb0hvWHFrR0FHN1VMVXpJbGZicFlYUzczTUFLU2tTZHFXWXVnbUFaYjM5WGJfOWtVb1NuMl9YbFNkNXA5RzMySHlOSWtxcVFpSnZzVWhPUVk?oc=5", "source_name": "Reuters", "published_at": "2021-05-13T07:00:00+00:00", "published_display": "13 May 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Samsung BioLogics, Pfizer deny report on COVID-19 vaccine production in S.Korea", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPRHRxcVFQN2JDWWl5NHhPaHAtOXdUN3c3c0hFa1Fza01ZWkVLV1VOcWxBM1BLRHF2ZkJ0NWZmaXlJRlkxTVRlMjFEOXNXTUxwMjdsbVEtcUhwVExhcVhNNDhzT3BxRUpxak9KUEwwM0hiNkRwLUFXQ3JqTXZCT0JUdnVNRXA5S3pNTk5pbEFIcThMY3hJbFJYdVM1NFBOYUJqQUJLYTVVZFk2b2hBQkhzWkh4cnVUYk1fb3ZZenBGNkFGSVBMVW9Vbw?oc=5", "source_name": "Reuters", "published_at": "2021-05-12T07:00:00+00:00", "published_display": "12 May 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 65, "total_relevant": 14, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 11, "score": 55, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 88, "events": [{"event": "general", "label": "Market update", "weight": 7.1, "count": 11}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1395000.0, "latest_week": "2026-07-10", "one_week_move": -1.8, "four_week_move": 7.7, "twelve_week_move": -12.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.623168, "market_dynamics_buy_signal": false, "relative_strength": -47.192464, "fair_value_gap": -3.7, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.0668, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.8% over one week, +7.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Ad Hoc News", "count": 4}, {"label": "BioWorld News", "count": 4}, {"label": "Reuters", "count": 3}, {"label": "TradingView", "count": 1}, {"label": "Seoul Economic Daily", "count": 1}, {"label": "PR Newswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Earnings", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "88/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.8% over one week, +7.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Samsung Biologics stock trades near record levels as contract manufacturing demand supports revenue"}], "updated_at": "2026-07-17T23:57:14.537609+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}